TetraQ provides a range of services
across the four core disciplines of preclinical drug development
as well as Program Management and Consultancy Services:
TetraQ provides services to companies that are developing new
drugs and seeking assistance with selecting or confirming a drug
candidate. TetraQ is also able to assist its clients by conducting
full preclinical drug characterisation packages (including GLP
services) that may be submitted internationally to regulatory
bodies with a view to starting clinical trials.
Preclinical tests vary widely in complexity, costs, duration
and importance. Careful choice of tests in the early stages may
save significant expenditure on a drug that fails the final preclinical
hurdles.
To help navigate clients through the process, TetraQ has prepared
the "Preclinical Drug Development Roadmap" which shows
our view of how the preclinical services fit together, and also
how TetraQ may be able to help your company.
Click
here to open the TetraQ Drug Development Roadmap...
| 
